Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 145540
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 132
  • list Pharmaceuticals and Healthcare

Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes.

Scope of the Report:

This report focuses on the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Sanofi

Takeda

Eli Lilly

Merck

Novo Nordisk

Bristol-Myers Squibb

Pfizer

AstraZeneca

GlaxoSmithKline

Boehringer Ingelheim

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Nesina

Tradjenta

Onglyza

Januvia

Others

Market Segment by Applications, can be divided into

Type 2 Diabetes

Others

There are 15 Chapters to deeply display the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market.

Chapter 1, to describe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, with sales, revenue, and price of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Introduction

1.2 Market Analysis by Type

1.2.1 Nesina

1.2.2 Tradjenta

1.2.3 Onglyza

1.2.4 Januvia

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Type 2 Diabetes

1.3.2 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Business Overview

2.1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Takeda

2.2.1 Business Overview

2.2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novo Nordisk

2.5.1 Business Overview

2.5.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bristol-Myers Squibb

2.6.1 Business Overview

2.6.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 AstraZeneca

2.8.1 Business Overview

2.8.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 GlaxoSmithKline

2.9.1 Business Overview

2.9.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Boehringer Ingelheim

2.10.1 Business Overview

2.10.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturer Market Share in 2017

3.3.2 Top 6 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Analysis by Regions

4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Regions

4.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Regions (2013-2018)

4.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Regions (2013-2018)

4.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

4.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

4.5 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

5 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries

5.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Countries

5.1.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Countries (2013-2018)

5.1.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Countries (2013-2018)

5.2 United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

5.3 Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

5.4 Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

6 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries

6.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Countries

6.1.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Countries (2013-2018)

6.2 Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

6.3 UK Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

6.4 France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

6.5 Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

6.6 Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

7 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries

7.1 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Countries (2013-2018)

7.2 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

7.3 Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

7.4 Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

7.5 India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

8 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries

8.1 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Countries

8.1.1 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Countries (2013-2018)

8.1.2 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

8.3 Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

8.4 Colombia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

9 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries

9.1 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

9.3 UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

9.4 Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

9.5 Nigeria Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

9.6 South Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2013-2018)

10 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Segment by Type

10.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Type (2013-2018)

10.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Type (2013-2018)

10.2 Nesina Sales Growth and Price

10.2.1 Global Nesina Sales Growth (2013-2018)

10.2.2 Global Nesina Price (2013-2018)

10.3 Tradjenta Sales Growth and Price

10.3.1 Global Tradjenta Sales Growth (2013-2018)

10.3.2 Global Tradjenta Price (2013-2018)

10.4 Onglyza Sales Growth and Price

10.4.1 Global Onglyza Sales Growth (2013-2018)

10.4.2 Global Onglyza Price (2013-2018)

10.5 Januvia Sales Growth and Price

10.5.1 Global Januvia Sales Growth (2013-2018)

10.5.2 Global Januvia Price (2013-2018)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2013-2018)

10.6.2 Global Others Price (2013-2018)

11 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Segment by Application

11.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2013-2018)

11.2 Type 2 Diabetes Sales Growth (2013-2018)

11.3 Others Sales Growth (2013-2018)

12 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2018-2023)

12.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Growth Rate (2018-2023)

12.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by Regions (2018-2023)

12.2.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2018-2023)

12.2.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2018-2023)

12.2.3 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2018-2023)

12.2.4 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2018-2023)

12.2.5 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2018-2023)

12.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by Type (2018-2023)

12.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Type (2018-2023)

12.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share Forecast by Type (2018-2023)

12.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by Application (2018-2023)

12.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Application (2018-2023)

12.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Picture

Table Product Specifications of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Figure Global Sales Market Share of Dipep

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery